The global capnography devices market is expected to grow at a CAGR of 6.3% during the forecast period with its market size valued at USD 365.0 million in 2020. Globally, capnography devices industry players are undertaking product innovations and technological upgradations that are enabling the manufacturers to gain competitive advantage across the globe.

Capnography is used for assessing ventilation that is different form oxygenation. Capnograph is a waveform that observes the CO2 level at each phase of the respiratory cycle and is generally in a rectangular shape and is also used for measuring and displaying the respiratory rate.

Download Free Sample Copy Of Research Report: https://www.vynzresearch.com/healthcare/capnography-device-market/request-sample

Based on end user, the global capnography devices market is categorised into ambulatory care centers (ACCs), hospitals, and others. Amongst these segments, hospitals are anticipated to generate largest revenue owing to rapid use of these devices for treating various diseases globally.

Capnography devices market in North America is anticipated to generate largest revenue of owing to increasing number of respiratory diseases cases occurring in the region owing to unhealthy lifestyles of the population along with high level of stress prevailing amongst the citizens. Furthermore, strict regulatory procedures implemented in the region for securing patients along with new reimbursement plans are other factors that are pertaining towards the growth of capnography devices market in the region.

Some of the players having prominent presence in the global capnography devices market include Philips Healthcare, Smiths Medical, Welch Allyn, Masimo Corporation, Nihon Kohden Corporation, Dragerwerk AG & Co. KGaA, Inc., Medtronic, Inc., Nonin Medical, Inc., CareFusion Corporation, and DiaMedica, Inc.

Source: VynZ Research